Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology | MicrobiomeTrials← Back to trialsNCT07815093
Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-10-01Est. Completion: 2028-04-01
Enrollment target: 11,000 participants Other microbiome trials you might be interested in
Oesophageal Squamous Cell CarcinomaOesophageal AdenocarcinomaGastric AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)CholangiocarcinomaHepatocellular Carcinoma (HCC)Colorectal Adenocarcinoma
The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlie…
Maidstone, United KingdomEst. completion Feb 2, 2028
Colorectal Adenomatous PolypColorectal Carcinoma
Familial Adenomatous Polyposis
Multiple Adenomatous Polyps
The purpose of this phase I trial is to test the safety and cancer preventive effects of different doses of ONC201 in pe…
Ann Arbor, United StatesEst. completion May 1, 2027
Metastatic Colorectal Cancer
To find the recommended dose of ulixertinib that can be given in combination with cetuximab and/or encorafenib to patien…
Houston, United StatesEst. completion Mar 28, 2028